Citius Pharmaceuticals, Inc. (CTXR) Financials

CTXR Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 132.5 million 63.5 million
Dec. 31, 2025 140.4 million 46.9 million
Sept. 30, 2025 130.9 million 53.4 million
June 30, 2025 127.7 million 60.1 million

CTXR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -1.3 million ?
Dec. 31, 2025 -13.0 million 4.3 million
Sept. 30, 2025 -11.9 million 2.9 million
June 30, 2025 -5.4 million 2.7 million

CTXR Net Income

No data available :(

CTXR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 4.6 million 636667 -
Dec. 31, 2025 7.7 million - 829646
Sept. 30, 2025 4.3 million - 813273
June 30, 2025 6.1 million - 881651

CTXR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 22.4 million
Dec. 31, 2025 21.5 million
Sept. 30, 2025 18.1 million
June 30, 2025 11.0 million

CTXR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 1.6 million 26.4 million -
Dec. 31, 2025 - 1.6 million 5.7 million -
Sept. 30, 2025 4 1.6 million 1.2 million -
June 30, 2025 - 1.6 million 7.2 million -

CTXR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.7 million 328878
Dec. 31, 2025 3.9 million 1.4 million
Sept. 30, 2025 - 62038
June 30, 2025 - 41367

CTXR

Price: $0.55

52 week price:
0.48
2.48

Earnings Per Share: -2.46 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 674400

Ebitda: -9.5 million

Market Capitalization: 6.5 million

Links: